Multiple Sclerosis: From Molecules to Treatment

Author： Broadley Simon A  

Publisher： MDPI

E-ISSN： 1422-0067|14|4|7598-7602

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.14, Iss.4, 2013-04, pp. : 7598-7602

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis

By Kolb-Mäurer Annette   Goebeler Matthias   Mäurer Mathias  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 14951-14960

MDPI

Access to resources Recommend Favorite

Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis

By Chiba Kenji   Adachi Kunitomo  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 514-528

MDPI

Access to resources Recommend Favorite

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases

By Rau Daniela   Lang Michael   Harth Andreas   Naumann Markus   Weber Frank   Tumani Hayrettin   Bayas Antonios  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-06 ,pp. : 14669-14676

MDPI

Access to resources Recommend Favorite

The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis

By Hestvik Anne Lise K.  

Toxins, Vol. 2, Iss. 4, 2010-04 ,pp. : 856-877

MDPI

Access to resources Recommend Favorite

From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A

By Berge Tone   Sørum Leikfoss Ingvild   Harbo Hanne F.  

International Journal of Molecular Sciences, Vol. 14, Iss. 3, 2013-02 ,pp. : 4476-4497

MDPI

Access to resources Recommend Favorite